Scientific Program
|
Opening Ceremony and Plenary Forum |
|
|
Time: 09:00-12:00, July 22, 2023 |
|
| Moderator | To Be Confirmed Soon |
|
Time |
Speeches and Speakers |
| 09:00-09:30 | Speech Opportunity Available |
| 09:30-10:00 | Title: From Structure-guided Drug Discovery in Academia to Drugs on the Market for Cancer in Astex Pharma Dr. Tom Blundell, Director of Research and Professor Emeritus, University of Cambridge, UK |
| 10:00-10:30 | Title: Directed Gene Delivery Via Targeted Exosomes to Cancer Dr. A. C. Matin, Professor, Stanford University School of Medicine, USA |
| 10:30-11:00 | Title: The Origin of Bladder Cancer Dr. Bogdan Czerniak, Professor, The University of Texas M. D. Anderson Cancer Center, USA |
|
11:00-11:30 |
Title: TBD Dr. Russel J. Reiter, Professor, University of Texas Health Science Center, USA |
| 11:30-12:00 | Speech Opportunity Available |
|
Session 101: Advances in Cancer Cell Biology |
|
|
Time: 13:30-17:10, July 22, 2023 |
|
|
Chair |
Dr. Rony Seger, Professor, Weizmann Institute of Science, Israel |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Title: TBD |
|
14:00-14:25 |
Title: The Nuclear Translocation of ERK as a Therapeutic Target for Cancer and Inflammation |
|
14:25-14:50 |
Title: TBD |
|
14:50-15:15 |
Title : Cancer-testis Antigens MAGEA Proteins are Incorporated Into Extracellular Vesicles Released by Cells |
|
15:15-15:30 |
Coffee Break |
|
15:30-15:55 |
Title: TBD |
|
15:55-16:20 |
Title: Molecular Approach of Uterine Mesenchymal Tumor for Development of TherapyDr. Takuma Hayashi, Professor, National Hospital Organization Kyoto Medical Center, Japan |
|
16:20-16:45 |
Title: Claudin-1, A New Tumor Suppressor Protein in Triple-Negative Breast Cancer Cells? |
|
17:45-17:10 |
Title: The Molecular Signature of Metastasis in the Early Stages of Clear Cell Renal Cell Carcinoma |
| Session 201: Artificial Intelligence and Machine Learning in Cancer Diagnosis | |
|
Time: 13:30-17:10, July 22, 2023 |
|
| Chair | Call for Chair |
|
Time |
Speeches and Speakers |
| 13:30-13:35 | Chair's Introduction |
| 13:35-14:00 | Speech Opportunity Available |
| 14:00-14:25 | Title: TBD Dr. Rebecca Hallows, Rolls-Royce, UK |
| 14:25-14:50 | Title : Field-assisted Paper Spray Mass Spectrometry for the Quantitative Evaluation of Imatinib Levels in Plasma Dr. Pietro Traldi, Professor, Nano-inspired Biomedicine Lab., Institute of Paediatric Research - Città della Speranza, Corso Stati Uniti, Italy |
| 14:50-15:15 | Title : Bio-Spectroscopy as a Cancer Diagnostic Tool Dr. P. Bertemes-Filho, Titular Professor, The State University of Santa Catarina, Brazil |
| 15:15-15:30 | Coffee Break |
| 15:30-15:55 | Title: Sub-THz spectroscopy for fingerprinting Biological Molecules used for early diagnosis of cancers and presence of Coronoviruse Dr. Tatiana Globus, Managing Director, Vibratess, LLC, USA |
| 15:55-16:20 | Title: Subclinical Atherosclerosis in Cuban Adolescents and Young Adults with Congenital Adrenal Hyperplasia Due To 21-Hydroxylase Deficiency Dr. Tania Mayvel Espinosa Reyes, National Institute of Endocrinology, Cuba |
| 16:20-16:45 | Title: MultiKOC: Multi-One-Class Classifier Based K-Means Clustering Dr. Loai Abdallah, Yezreel Valley Academic College, Israel |
| 17:45-17:10 |
Title: An Effective Approach Using Ensemble Learning to Diagnose Blood Cancer |
|
Session 301: New Anti-cancer Drug Discovery, Design, and Optimization |
|
|
Time: 13:30-17:10, July 22, 2023 |
|
| Chair | Call for Chair |
|
Time |
Speeches and Speakers |
| 13:30-13:35 | Chair's Introduction |
| 13:35-14:00 | Title: Technologies to Improve the Specificity and Activity of Novel Anticancer Agents Dr. Mark Krul, Professor, Aglaia Oncology Fund II, The Netherlands |
| 14:00-14:25 | Title : Allosteric Protein Degraders in the Fight Against Cance Dr. Vehary Sakanyan, Professor, University of Nantes, France |
| 14:25-14:50 | Title : Anti Cancer : Rational Design by Trojan Horse Strategy Dr. Nohad Al Omar, College of Pharmacy, Knowledge university, Iraq |
| 14:50-15:15 | Title: TBD Dr. Zvi Naor, Professor, Tel Aviv University, Israel |
| 15:15-15:30 | Coffee Break |
| 15:30-15:55 | Title: Graphene/PU/PMMA Composite for Designing of Prostheses: Effect of Blood Flow on Composite at Several Temperatures Dr. Norma-Aurea Rangel-Vazquez, Instituto Tecnologico de Aguascalientes, Mexico |
| 15:55-16:20 | Title: TBD Dr. Dagmara Baraniak, Institute of Bioorganic Chemistry, Polish Academy of Sciences, Pozna��, Poland |
| 16:20-16:45 | Title: TBD Dr. Michael H. Shaw, Takeda Pharmaceuticals International Co., USA |
| 17:45-17:10 |
Title: Molecular iodine in chemoresistant cancers Dr. Carmen Aceves, Universidad Nacional Autómona de México, México |
|
Session 401: Gynecologic Cancer |
|
|
Time: 13:30-17:10, July 22, 2023 |
|
| Chair | Call for Chair |
|
Time |
Speeches and Speakers |
| 13:30-13:35 | Chair's Introduction |
| 13:35-14:00 | Title: TBD Dr. Felix JC, Professor and Vice Chair Medical College of Wisconsin, USA |
| 14:00-14:25 | Title: TBD Dr. Michał Kiełbik, Institute of Medical Biology, Polish Academy of Sciences, Poland |
| 14:25-14:50 | Title: TBD Dr. Raffaele Tinelli, Malzoni Medical Center, Italy |
| 14:50-15:15 | Title: Neoadjuvant Chemotherapy With Quick Cisplatin-VP 16 Followed by Robotic Radical Trachelectomy in Stage 1B2 Cervical Cancer Dr. Joo Hee Yoon, Professor, The Catholic University of Korea, Korea |
| 15:15-15:30 | Coffee Break |
| 15:30-15:55 | Title: TBD Dr. Nash S. Moawad, Associate Professor, University of Florida College of Medicine, USA |
| 15:55-16:20 | Title: TBD Dr. Ekaterini Domali, University of Athens School of Medicine, Alexandra Hospital, Greece |
| 16:20-16:45 | Title: TBD Dr. Ilaria Betella, European Institute of Oncology IRCCS, Italy |
| 17:45-17:10 | Title: Multimodal Therapy of Primary Ovarian Cancer Dr. Michael Friedrich, Professor, Klinik für Frauenheilkunde und Geburtshilfe, Germany |
|
Session 402: Breast Cancer |
|
|
Time: 13:30-17:10, July 22, 2023 |
|
|
Chair |
Dr. Peiying Yang, Associate Professor, The University of Texas MD Anderson Cancer Center, USA |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair's Introduction |
|
13:35-13:55 |
Title: Ultra-hypofractionation Radiotherapy with SIB in Early Breast Cancer: Clinical Implementation |
|
13:55-14:15 |
Title: The Prognostic Value of Immunohistochemical Expression of PD1 and PD-L1 on Tumor Cells and Tumor-Infiltrating Stromal Immune Cells in Primary Breast Cancer |
|
14:15-14:35 |
Title: TBD |
|
14:35-14:55 |
Title: Supporting and Empowering Breast Cancer Patients through their Trajectory – the Israeli Experience |
|
14:55-15:15 |
|
|
15:15-15:30 |
Coffee Break |
|
15:30-15:50 |
Title: TBD |
|
15:50-16:10 |
Title : Sugar and Breast Cancer: What we Have Learned |
|
16:10-16:30 |
Title : Choriocarcinoma Following Live Birth: Is It a Delay in Diagnosis or Ignorance of the Disease |
|
16:30-16:50 |
Title: Female Students’ Knowledge, Beliefs, Attitude and Practice of Breast Self-Examination in a University in the Western Cape |
|
Session 501: Molecular Targets and Cancer Therapeutics |
|
|
Time: 13:30-17:10, July 22, 2023 |
|
| Chair | Dr. Thomas Boldicke, Project Leader, Helmholtz Centre for Infection Research, Germany |
|
Time |
Speeches and Speakers |
| 13:30-13:35 | Chair's Introduction |
| 13:35-14:00 | Title: Therapeutic Potential of Intrabodies for Cancer Immunotherapy: Current Status and Future Directions Dr. Thomas Boldicke, Project Leader, Helmholtz Centre for Infection Research, Germany |
| 14:00-14:25 | Title: TBD Dr. Dorit Avni, Sphingolipids, MIGAL - Galilee Research Institute, Israel |
| 14:25-14:50 | Title: Novel Targeted Therapies For Lymphoma Dr. Lapo Alinari, The Ohio State University Medical Center, USA |
| 14:50-15:15 | Title: Characteristics, Management, and Prognostic Implications of Adverse Effects of Immune Checkpoint Inhibitors: A Systematic Review. Dr. G. Juan-Carpena, Hospital General Universitario de Alicante, Spain |
| 15:15-15:30 | Coffee Break |
| 15:30-15:55 | Title: Combined Blockade of MEK and PI3KCA as an Effective Antitumor Strategy in HER2 Gene Amplified Human Colorectal Cancer Models Dr. Valentina Belli, Università Degli Studi Della Campania "Luigi Vanvitelli" Italy |
| 15:55-16:20 | Title : Stromal Reprogramming with Translatable Nanomedicines Overcomes Checkpoint Blockade and Chemotherapy Resistance in Pancreatic Cancer Dr. Hiroaki Kinoh, Innovation Centre of NanoMedicine, Japan |
| 16:20-16:45 | Title : Nanostructure Empowers Active Tumor Targeting in Ligand�\Based Molecular Delivery Dr. Ramón Mangues, Creu i Sant Pau, Spain |
| 17:45-17:10 | Title : Update in Urothelial Carcinoma; What’S New Dr. Emmanuel Seront, Universití Catholique de Louvain, Belgium |
|
Session 601: Cancer Rehabilitation, Cancer Nursing and Care |
|
|
Time: 13:30-17:10, July 22, 2023 |
|
| Chair | Call for Chair |
|
Time |
Speeches and Speakers |
| 13:30-13:35 | Chair's Introduction |
| 13:35-14:00 | Title: TBD Dr. Jacqueline T. Norrell, Rutgers Cancer Institute of New Jersey, USA |
| 14:00-14:25 | Title : Dermocosmetic Management of the Skin Adverse Effects in Oncology Patients Dr. Athanasia Varvaresou, Professor, University of West Attica, Greece |
| 14:25-14:50 | Speech Opportunity Available |
| 14:50-15:15 | Title: TBD Dr. Penny Daugherty, Oncology Nurse Navigator, Northside Hospital Cancer Institute, USA |
| 15:15-15:30 | Coffee Break |
| 15:30-15:55 |
Title: Improving Cancer MDT performance in Western Sydney – Three Years’ Experience Dr. Lynleigh Evans, Senior Medical Advisor, Western Sydney Local Health District, Australia |
| 15:55-16:20 | Title: The Short Affection of Radiotherapy Interruption Dr. Xiangpan Li, Director of the Department of Radiotherapy, Renmin Hospital of Wuhan University, China |
| 16:20-16:45 | Title : Improving Medication Adherence and Symptom Management in Patients with Cancer Dr. Carla Schaefer, Associate Chief Nursing Officer, The State University of New Jersey, USA |
| 17:45-17:10 | Speech Opportunity Available |
Hosting Organization
Official Travel Agency
Media
Partners
Contact Us
Add: Life Science Innovation Center BLD 3-2, 43 Torch Road,
High Tech Park, Dalian, LN 116023, China
© 2003-2023 All rights reserved by BIT Congress
